Abstract
The aim of this randomized, double-blind, placebo-controlled clinical trial was to evaluate the effects of dezocine on the incidence and severity of myoclonus induced by etomidate. Patients (108) were randomly assigned to one of two groups to receive either 0.1 mg kg−1 of dezocine (n = 54; Group D) or saline (n = 54; Group S) intravenously 1 min before 0.3 mg kg−1 etomidate was given. The occurrence and severity (observational score of 0–3) of myoclonus was assessed for 2 min after administration of etomidate. The incidence and the intensity of myoclonus were significantly lower in Group D (0 %) than in Group S (75.9 %) (P < 0.01), and all patients showed stable cardiovascular profiles. The results suggest that infusion of 0.1 mg kg−1 dezocine 1 min before etomidate administration is effective for suppressing myoclonus induced by etomidate during induction of general anesthesia without significant side-effects.
References
Doenicke A, Roizen MF, Nebauer AE, Kugler A, Hoernecke R, Beger-Hintzen H. A comparison of two formulations for etomidate, 2-hydroxypropyl-β-cyclodextrin (hpcd) and propylene glycol. Anesth Analg. 1994;79:933–9.
Doenicke AW, Roizen MF, Kugler J, Kroll H, Foss J, Ostwald P. Reducing myoclonus after etomidate. Anesthesiology. 1999;90:113–9.
Berry JM, Merin RG. Etomidate myoclonus and the open globe. Anesth Analg. 1989;69:256–9.
Ebrahim ZY, DeBoer GE, Luders H, Hahn JF, Lesser RP. Effect of etomidate on the electroencephalogram of patients with epilepsy. Anesth Analg. 1986;65:1004–6.
Gancher S, Laxer KD, Krieger W. Activation of epileptogenic activity by etomidate. Anesthesiology. 1984;61:616–8.
Grant IS, Hutchison G. Epileptiform seizures during prolonged etomidate sedation. Lancet. 1983;2:511–2.
Reddy RV, Moorthy SS, Dierdorf SF, Deitch RD Jr, Link L. Excitatory effects and electroencephalographic correlation of etomidate, thiopental, methohexital, and propofol. Anesth Analg. 1993;77:1008–11.
Voss LJ, Sleigh JW, Barnard JP, Kirsch HE. The howling cortex: seizures and general anesthetic drugs. Anesth Analg. 2008;107(5):1689–703.
Bausch SB, Esteb TM, Terman GW, Chavkin C. Administered and endogenously released kappa opioids decrease pilocarpine-induced seizures and seizure-induced histopathology. J Pharmacol Exp Ther. 1998;284:1147–55.
Simonato M, Romualdi P. Dynorphin and epilepsy. Prog Neurobiol. 1996;50(5–6):557–83.
Stockham RJ, Stanley TH, Pace NL, Gillmor S, Groen F, Hilkens P. Fentanyl pretreatment modifies anaesthetic induction with etomidate. Anaesth Intensive Care. 1988;16:171–6.
Hueter L, Schwarzkopf K, Simon M, Bredle D, Fritz H. Pretreatment with sufentanil reduces myoclonus after etomidate. Acta Anaesthesiol Scand. 2003;47:482–4.
Schwarzkopf KR, Hueter L, Simon M, Fritz HG. Midazolam pretreatment reduces etomidate-induced myoclonic movements. Anaesth Intensive Care. 2003;31:18–20.
Ri HS, Shin SW, Kim TK, Baik SW, Yoon JU, Byeon GJ. The proper effect site concentration of remifentanil for prevention of myoclonus after etomidate injection. Korean J Anesthesiol. 2011;61:127–32.
Solbrig MV, Adrian R, Baratta J, Lauterborn JC, Koob GF. Kappa opioid control of seizures produced by a virus in an animal model. Brain. 2006;129:642–54.
Conflict of interest
None of the authors has any conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Trial registration: Chinese Clinical Trial Registry (ID: ChiCTR-PRC-13003152). The registration information can be found on the following website: http://apps.who.int/trialsearch/Trial.aspx?TrialID=ChiCTR-PRC-13003152.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
He, L., Ding, Y., Chen, H. et al. Dezocine pretreatment prevents myoclonus induced by etomidate: a randomized, double-blinded controlled trial. J Anesth 29, 143–145 (2015). https://doi.org/10.1007/s00540-014-1854-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00540-014-1854-2